Loading insider details...
Beta
Latest Form 4 (Jun 2, 2025): Grant/Award of 33,000 ESPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 2, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 33,000 | n/a |
| May 24, 2024 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 23,000 | n/a |
| Apr 22, 2024 | TFF Pharmaceuticals, Inc. (TFFP) | Grant/Award | 4,667 | n/a |
| Jun 16, 2023 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 5,150 | n/a |
| May 11, 2023 | Esperion Therapeutics, Inc. (ESPR) | Purchase | 8,111 | $12.1K |
| May 27, 2022 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 40,000 | n/a |